Bicara Therapeutics Inc. logo

Bicara Therapeutics Inc. (BCAX)

Market Closed
17 Jul, 20:00
NASDAQ (NMS) NASDAQ (NMS)
$
27. 76
+0.16
+0.5797%
$
1.54B Market Cap
- P/E Ratio
- Div Yield
471,700 Volume
0 Eps
$ 27.6
Previous Close
Add Transaction
Day Range
26.64 28.24
Year Range
9.57 30.99
Want to track BCAX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Name Time Cons. EPS Eps
Bicara Therapeutics Inc. logo
BCAX Bicara Therapeutics Inc.
19 May 2026
-
-
Bicara Therapeutics Inc. logo
BCAX Bicara Therapeutics Inc.
26 Mar 2026
-
-
Bicara Therapeutics Inc. logo
BCAX Bicara Therapeutics Inc.
11 Nov 2025
-
-
Bicara Therapeutics Inc. logo
BCAX Bicara Therapeutics Inc.
3 Sep 2025
-
-
Bicara Therapeutics Inc. logo
BCAX Bicara Therapeutics Inc.
12 Aug 2025
-
-
Bicara Therapeutics Inc. logo
BCAX Bicara Therapeutics Inc.
13 May 2025
-
-
Bicara Therapeutics Inc. logo
BCAX Bicara Therapeutics Inc.
27 Mar 2025
-
-
Bicara Therapeutics Inc. logo
BCAX Bicara Therapeutics Inc.
12 Nov 2024
-
-

BCAX Earnings Reports FAQ

What is the earnings per share (EPS) for BCAX?

The current EPS is 0.

What is the company's earnings growth rate?

Bicara Therapeutics Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.

When is the next earnings release date?

Bicara Therapeutics Inc has not announced its next earnings release date.

What were the most recent quarterly earnings?

The most recent quarterly earnings for Bicara Therapeutics Inc are not available at this time.

What is the price-to-earnings (P/E) ratio?

There is no P/E ratio for BCAX at this time, as Bicara Therapeutics Inc has no recent EPS data to calculate it.